Sep 2018 – AATI is pleased to announce new appointees to its Advisory Board. The new Advisory Board Members will help AATI with: greater strategic direction; broadening industry connections for its Australian cohorts into drug development, health insurance and med-tech sectors within Asia; and potential new export markets comprising Europe and the UK. AATI is supported by the Australian Government Department of Industry, Innovation and Science through an Incubator Support initiative grant as part of the Entrepreneurs’ Programme.
AATI’s Advisory Board
Glenn Cross (former CEO of AusBiotech Ltd.)
Prof. David Anderson (Deputy Director of Burnet Institute)
Russell Bateman (COO CPIC Allianz Health)
Shane Lawrence (Joint Managing Director of Questra Ltd.)
Dr. Brendan Shaw (Former CEO of Medicines Australia)
Cindy Zhai (AATI China Partner)
The breadth of experience and talent strengthens AATI’s ability to progress and tailor services and needs for
organisations that plan to undertake business within China and Australia.
Upcoming AATI events: Melbourne Bootcamp
AATI’s Melbourne bootcamp is scheduled for Oct 25-26th and is to be hosted by FB Rice within their offices. Like AATI’s previous two Bootcamps in Brisbane and Sydney, the Melbourne bootcamp will provide key skills and information critical to informing the Asia market entry plans and key decision making for its attendees.
Following in November is AATI’s Asia bootcamp which will be held at the headquarters of our Asian partner
JIMC (Asia’s largest life science incubator). The upcoming Asia bootcamps key outcomes will provide attendees to see first-hand the opportunities available within Asia and present to local industry partners and early stage investors.
For more information or registration for the Victorian AATI Bootcamp please visit:
For further information contact: